Trials / Not Yet Recruiting
Not Yet RecruitingNCT06338800
One Session Virtual Reality During Ongoing Treatment for Anxiety: Feasibility in Children and Adolescents
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Accare · Academic / Other
- Sex
- All
- Age
- 8 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to evaluate one session with exposure with Virtual Reality (VR) in in children and adolescents, aged 8-18 years with an anxiety disorder. The main questions it aims to answer are: 1. What are the expectations of children and adolescents and therapists with VR exposure? 2. What is the acceptability of the VR session (positive and negative effects)? 3. What are possible working mechanisms of VR exposure? During ongoing treatment, participants will receive a session of exposure with VR.
Detailed description
Cognitive behavioral therapy is an effective treatment for anxiety disorders, with exposure as the most important working ingredient. Exposure therapy can be challenging to implement in face-to-face settings. Virtual reality (VR) has emerged as a promising tool for delivering exposure therapy. In the current study, the researchers will examine children and adolescents that will participate in a single session of VR exposure during their regular treatment (n=30). Willingness to participate in exposure in vivo will be assessed directly before and directly after the session. During the session anxiety, idiosyncratic expectations, and self-efficacy will be assessed. Expectations will be measured before the session and acceptability after the session.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | One session exposure with Virtual Reality | Participants will receive one session exposure with virtual reality from their therapists. |
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2025-04-01
- Completion
- 2025-12-01
- First posted
- 2024-04-01
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT06338800. Inclusion in this directory is not an endorsement.